|
Any method out there for N-Nitrosomethylphenidate
|
|
0
|
405
|
March 31, 2023
|
|
Korea FDA just published a compilation of analytical methods document!
|
|
13
|
2663
|
March 31, 2023
|
|
LoQ of 0.03 ppm
|
|
5
|
1293
|
March 15, 2023
|
|
Testing of finished product when working with hard gelatin capsules
|
|
2
|
743
|
March 6, 2023
|
|
UHPLC-APCI-TQ-MS analytical method capable of quantifying eight nitrosamine impurities from five different Metformin Formulations -Pub
|
|
1
|
896
|
March 2, 2023
|
|
In the hunt for a Nitrosamine Universal Method?
|
|
11
|
839
|
December 12, 2022
|
|
New Standard Provides Test Method for Carcinogens in Water
|
|
2
|
533
|
January 27, 2023
|
|
Can we build a list of 'impossible to synthesized Nitrosamines'?
|
|
10
|
1541
|
January 11, 2023
|
|
Reference Standards
|
|
5
|
484
|
December 20, 2022
|
|
Nitroso-Diclofenac mutagenicity
|
|
13
|
1674
|
December 21, 2022
|
|
GC-MS Method for six nitrosamines analysis in Organic Solvents
|
|
1
|
459
|
December 14, 2022
|
|
FDA - Rapid quantitation of four nitrosamine impurities in angiotensin receptor blocker drug substances
|
|
0
|
474
|
December 12, 2022
|
|
Analyse de N-Methyl-N'-Nitro-N-Nitrosoguanidine (NMNG)
|
|
0
|
276
|
December 5, 2022
|
|
A Diagnostic Nitrosamines detection approach for Pharmaceuticals Method
|
|
0
|
403
|
October 18, 2022
|
|
GC-MS/MS & HS-SPME for 14 nitrosamines in 44 pharmaceuticals
|
|
3
|
990
|
October 1, 2022
|
|
LC-APCI-MS/MS method for the estimation of Nitrosamines in Sartan drug substances and tablets
|
|
0
|
496
|
September 26, 2022
|
|
Selection of MDD in Finished products
|
|
0
|
400
|
September 5, 2022
|
|
How to deal with Nitrosamine standards?
|
|
2
|
494
|
August 25, 2022
|
|
Any experience on Nitrosamines analysis in Sciex 7500?
|
|
5
|
521
|
August 15, 2022
|
|
Background noise in UPLC-MS/MS experience?
|
|
6
|
619
|
July 18, 2022
|
|
Best practice to decontaminate work area of Nitrosamines
|
|
9
|
855
|
July 6, 2022
|
|
Microfiltration and nitrosamine analytics
|
|
4
|
365
|
June 23, 2022
|
|
Determination of 13 Nitrosamines in Biological medicines using salting-out liquid-liquid extraction
|
|
0
|
471
|
June 17, 2022
|
|
The question of peak tailing in the detection of the released N-NO of Nadroparinum calcicum by chemiluminescence
|
|
1
|
313
|
June 15, 2022
|
|
Quantification of NDMA in Olmesartan by HPLC-MS/MS
|
|
0
|
309
|
June 14, 2022
|
|
亚硝胺杂质分析方法验证的可接受标准
|
|
3
|
464
|
June 2, 2022
|
|
Sample preparation - erythromycin estolate
|
|
1
|
277
|
May 3, 2022
|
|
Absolute Quantitationof N‑Nitrosamines by Coulometric Mass Spectrometry
|
|
0
|
306
|
April 27, 2022
|
|
Pharmaceutical samples containing NDMA, NDEA, or NDEA
|
|
2
|
345
|
April 23, 2022
|
|
Risk assessment for nitrosated pharmaceuticals: A future perspective
|
|
2
|
586
|
April 22, 2022
|